Alexander R. Ochman

Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia

Sherri L. Stewart, Troy D. Querec, Alexander R. Ochman et al. · Cancer Research · 2004 · 64 citations

The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes

Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 42 citations

MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase In Vitro That Improves Glucose Tolerance In Vivo

Michael S. Saporito, Alexander R. Ochman, Christopher A. Lipinski et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 39 citations

Synthesis and Pharmacological Evaluation of <i>N</i>-(3-(1<i>H</i>-Indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a Potent Antimitotic Agent

Rupa Shetty, Younghee Lee, Bin Liu et al. · Journal of Medicinal Chemistry · 2010 · 34 citations